Camp4 Therapeutics Corporation
CAMP
$1.55
-$0.04-2.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.09% | 0.15% | -2.22% | -15.30% | -2.22% |
| Total Depreciation and Amortization | 1.42% | -3.44% | -3.91% | -2.79% | 4.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.77% | 12.52% | 17.71% | 83.20% | -1.51% |
| Change in Net Operating Assets | 116.94% | -800.97% | 195.19% | -63.41% | -11.20% |
| Cash from Operations | 23.03% | -28.21% | 4.20% | -47.89% | -4.10% |
| Capital Expenditure | 100.00% | -1,760.00% | -8.23% | 100.00% | -42.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -1,760.00% | -8.23% | 100.00% | -42.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 135.29% | 25.98% | 10.59% | -0.49% | -172.00% |
| Issuance of Common Stock | -- | -- | 44,080.92% | 3,000.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 108.87% | 25.25% | 116,071.43% | -90.15% | -386.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.74% | -29.54% | 608.82% | -44.73% | -13.14% |